Information  X 
Enter a valid email address

Company Name matching 'Zealand Pharma'

Date
Time Source
Company
Announcement
23 Feb 2021 9:05 pm GNW   Zealand Pharma Zealand Pharma to participate in upcoming investor conferences
09 Feb 2021 9:05 pm GNW   Zealand Pharma Zealand Pharma to participate in SVB Leerink 9th Annual Global Healthcare Conference
04 Feb 2021 9:05 pm GNW   Zealand Pharma Zealand Pharma to Host R&D Day on March 5, 2021
11 Nov 2020 9:00 am GNW   Zealand Pharma Zealand Pharma:
05 Nov 2020 9:00 am GNW   Zealand Pharma Zealand Pharma hosts conference call on November 12 at 4 pm CET (10am ET) to present third quarter results for 2020
04 Sep 2020 11:00 am GNW   Zealand Pharma Zealand Pharma builds Global Medical Affairs function with world-renowned experts
03 Sep 2020 9:00 am GNW   Zealand Pharma Zealand Pharma to participate in upcoming investor conferences
06 Aug 2020 9:00 am GNW   Zealand Pharma Zealand Pharma hosts conference call on August 13 at 4 pm CET (10am ET) to present second quarter results for 2020
03 Aug 2020 9:00 am GNW   Zealand Pharma Zealand Pharma Continues to Build Investor Relations and Communications Function with the Appointment of Mads Kronborg
06 Jul 2020 12:00 pm GNW   Zealand Pharma Zealand Pharma Expands U.S. Operations, Opens New Boston Office
14 Jun 2020 4:00 pm GNW   Zealand Pharma Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association
13 Jun 2020 4:00 pm GNW   Zealand Pharma Zealand Pharma presents elaborated results on the use of regular human insulin delivered by V-Go® in older adults with type 2 diabetes, at the 80th Scientific Sessions of the American Diabetes Association
10 Jun 2020 7:00 am GNW   Zealand Pharma Zealand Pharma to leverage Intomics bioinformatics platform within peptide drug discovery and development process
01 Jun 2020 8:55 pm GNW   Zealand Pharma Zealand Pharma to attend Jefferies and Goldman Sachs Virtual Healthcare Conferences
20 Apr 2020 7:36 pm GNW   Zealand Pharma Zealand Pharma hosts conference call on May 14 at 4 pm CEST (10 am EDT) to present first quarter results for 2020
31 Mar 2020 2:45 pm GNW   Zealand Pharma Zealand Pharma submits New Drug Application to the U.S. Food and Drug Administration for the Dasiglucagon HypoPal® Rescue Pen for treatment of severe hypoglycemia
09 Mar 2020 12:26 pm GNW   Zealand Pharma Update: Zealand Pharma hosts conference call on March 12 at 4 pm CET (11 am EDT) to present full year results for 2019
27 Feb 2020 7:00 am GNW   Zealand Pharma Zealand Pharma to attend Credit Suisse 2020 Global Healthcare Conference
20 Feb 2020 6:30 pm GNW   Zealand Pharma Zealand Pharma to attend 9th Annual SVB Leerink Global Healthcare Conference
04 Dec 2019 1:55 pm GNW   Zealand Pharma Zealand Pharma initiates second Phase 3 trial with dasiglucagon for the treatment of congenital hyperinsulinism
28 Oct 2019 4:00 pm GNW   Zealand Pharma Zealand Pharma hosts conference call on November 14 at 4 PM CET (10 AM ET) to present third quarter results for 2019
29 Aug 2019 3:00 pm GNW   Zealand Pharma Zealand Pharma to attend Morgan Stanley 17th Annual Global Healthcare Conference
27 Aug 2019 9:00 am GNW   Zealand Pharma Zealand Pharma relocates headquarters to accommodate growth
01 Aug 2019 4:00 pm GNW   Zealand Pharma Zealand Pharma hosts conference call on August 15 at 4 pm CET (10 am EST) to present first half results for 2019
26 Jun 2019 7:00 am GNW   Zealand Pharma Zealand Pharma doses first subject in Phase 1 clinical trial with potential next generation dual-acting peptide therapeutic for short bowel syndrome
21 Jun 2019 8:00 am GNW   Zealand Pharma Zealand Pharma introduces new website to support people living with short bowel syndrome
11 Jun 2019 1:00 am GNW   Zealand Pharma Zealand Pharma presents dasiglucagon pivotal Phase 3 trial data at the 79th Scientific Sessions of the American Diabetes Association (ADA)
04 Jun 2019 3:00 pm GNW   Zealand Pharma Zealand Pharma to attend Citi European Healthcare Conference
27 May 2019 3:00 pm GNW   Zealand Pharma Zealand Pharma to attend Jefferies and Goldman Sachs Global Healthcare Conferences
22 May 2019 1:00 pm GNW   Zealand Pharma Beta Bionics and Zealand Pharma initiate home-use trial of the iLet™ bionic pancreas with dasiglucagon for autonomous bihormonal treatment of Type 1 diabetes
07 May 2019 12:00 pm GNW   Zealand Pharma Zealand Pharma enrolls first patient in Phase 3 extension study of glepaglutide for treatment for short bowel syndrome
06 May 2019 10:00 am GNW   Zealand Pharma Zealand Pharma hosts conference call on May 16 at 4 pm CET (10 am EST) to present first quarter results for 2019
11 Apr 2019 12:00 pm GNW   Zealand Pharma Zealand Pharma to attend ABG Sundal Collier Small & Mid Cap Seminar
08 Apr 2019 7:00 pm GNW   Zealand Pharma Zealand Pharma to attend Kempen Life Sciences Conference
02 Apr 2019 12:00 pm GNW   Zealand Pharma Zealand Pharma to attend Needham Healthcare Conference
07 Mar 2019 2:00 pm GNW   Zealand Pharma Zealand Pharma announces full-year 2018 results, strong cash position to support pipeline progress
06 Mar 2019 8:00 am GNW   Zealand Pharma Zealand Pharma doses first patient in Phase 3 trial with dasiglucagon for the treatment of congenital hyperinsulinism
01 Mar 2019 1:00 pm GNW   Zealand Pharma Zealand Pharma to attend Credit Suisse and BioCapital Healthcare Conferences
25 Feb 2019 3:00 pm GNW   Zealand Pharma Zealand Pharma hosts conference call on March 7 at 4 pm CET (10 am EST) to present fourth quarter and full year results for 2018
04 Jan 2019 11:00 am GNW   Zealand Pharma Zealand Pharma to attend JP Morgan Healthcare Conference and Oddo BHF Forum
  9:06 am GNW   Zealand Pharma Zealand Pharma completes equity investment in strategic partner Beta Bionics
14 Sep 2018 8:45 am GNW   Zealand Pharma Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
29 Nov 2017 9:37 am GNW   Zealand Pharma Zealand Pharma to attend three U.S. healthcare conferences in December
23 May 2017 7:40 am GNW   Zealand Pharma Positive Phase 2a results with microdoses of dasiglucagon support use in a dual-hormone artificial pancreas system
17 May 2017 2:24 pm GNW   Zealand Pharma CORRECTION: Zealand reports results for the first three months of 2017 (unaudited)
  2:04 pm GNW   Zealand Pharma Zealand reports results for the first three months of 2017 (unaudited)
15 Mar 2017 1:49 pm GNW   Zealand Pharma Zealand announces full-year results in line with guidance and releases its Annual Report for 2016
08 Feb 2017 6:48 am GNW   Zealand Pharma Zealand reports Q4 2016 Lyxumia® royalty revenue
17 Jan 2017 7:10 pm GNW   Zealand Pharma EU approval of Suliqua(TM) triggers USD 10 million milestone payment to Zealand
04 Jan 2017 7:07 am GNW   Zealand Pharma Zealand reports that Sanofi announces Soliqua(TM) 100/33 now available in the U.S
15 Oct 2010 6:00 am GNW   Zealand Pharma Positive Phase I data for ZP1848 in Crohn's Dis...
20 Sep 2010 11:16 am GNW   Zealand Pharma Positive Study Findings from Lixisenatide in Fi...
08 Jun 2010 6:00 am GNW   Zealand Pharma Zealand Pharma Announces An Extension of The Li...
06 May 2010 6:00 am GNW   Zealand Pharma Annual Review for 2009
15 Apr 2010 12:30 pm GNW   Zealand Pharma Positive Phase III Diabetes Data with Lixisenat...
08 Mar 2010 10:25 am GNW   Zealand Pharma Zealand Pharma Announces Augmentation of its Ma...
  10:25 am GNW   Zealand Pharma Zealand Pharma udnævner nye medlemmer til topl...
02 Mar 2010 8:13 am GNW   Zealand Pharma Zealand Pharma and PolyTherics enter Collaborat...
  8:13 am GNW   Zealand Pharma Zealand Pharma og PolyTherics indgår en samarb...


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t